Immunoglobulin G (IgG)

Immunoglobulin G (IgG) is the most abundant class of antibodies in human blood and extracellular fluid, accounting for approximately 75-80% of total circulating immunoglobulins. It is an essential component of the adaptive immune system and plays a central role in protecting the body against bacterial, viral, and other pathogenic infections. IgG is produced by plasma cells, which develop from activated B lymphocytes following exposure to specific antigens. Through its ability to recognize and bind to foreign substances, IgG contributes to the identification and elimination of pathogens, thereby maintaining immune homeostasis and providing long-term immune protection.

Structurally, IgG is a glycoprotein composed of four polypeptide chains: two identical heavy chains and two identical light chains, linked together by disulfide bonds to form a characteristic Y-shaped molecule. Each antibody molecule contains two antigen-binding fragments (Fab regions) and one crystallizable fragment (Fc region). The Fab regions are responsible for recognizing and binding specific antigens, whereas the Fc region interacts with various immune components, including Fc receptors on immune cells and proteins of the complement system. This structural organization enables IgG to perform several important immune functions.

IgG has four subclasses in humans: IgG1, IgG2, IgG3, and IgG4. These subclasses differ in their structural properties, biological activities, and abilities to activate immune responses. IgG1 and IgG3 are particularly effective in mediating antibody-dependent cellular cytotoxicity and activating the classical complement pathway. IgG2 is primarily involved in immune responses against polysaccharide antigens, such as those found on bacterial capsules, while IgG4 is associated with immune tolerance and can participate in responses to prolonged antigen exposure. The distribution and function of these subclasses are important for maintaining effective immune defense.

One of the most significant characteristics of IgG is its diverse range of biological functions. It can neutralize viruses and bacterial toxins by preventing their interaction with host cells. Additionally, IgG promotes opsonization, a process in which pathogens are coated with antibodies to facilitate their recognition and phagocytosis by macrophages and neutrophils. Certain IgG subclasses can also activate the complement system, enhancing pathogen elimination. IgG is the only antibody class that can efficiently cross the human placenta through the neonatal Fc receptor (FcRn), providing passive immunity to the developing fetus and newborn.

Beyond its physiological importance, IgG has considerable clinical and diagnostic significance. Measurement of total IgG levels and specific IgG antibodies is widely used to evaluate immune function, identify previous exposure to infectious agents, assess vaccine-induced immunity, and investigate immunological disorders. Abnormal IgG concentrations may be associated with immunodeficiency, chronic infections, autoimmune diseases, or certain hematological malignancies. IgG is a fundamental antibody class that contributes to pathogen recognition, immune regulation, and long-term protection. Its structural diversity, specialized biological functions, and clinical relevance make it an important subject in immunology, medical research, and diagnostic practice.

Subclasses of immunoglobulin G

Immunoglobulin G is divided into four distinct subclasses: IgG1, IgG2, IgG3, and IgG4. Although these subclasses share a common molecular architecture, they differ in their amino acid composition, hinge-region configuration, serum concentrations, antigen specificity, and biological activities. Such variations enable each subclass to perform specialized functions in immune surveillance and host defense. Their functional diversity is particularly evident in their interactions with antigens, complement proteins, and Fc receptors on immune cells.

Immunoglobulin G1 (IgG1): IgG1 constitutes approximately 60-65% of total circulating IgG, making it the predominant subclass in human serum. It is particularly effective against protein antigens derived from viruses, bacteria, and bacterial toxins. Its strong affinity for several Fc gamma receptors enables efficient recognition and elimination of antibody-coated pathogens by phagocytic cells. IgG1 also participates in antibody-dependent cellular cytotoxicity (ADCC), facilitating the destruction of infected or abnormal cells by natural killer cells. It efficiently activates the classical complement pathway, contributing to pathogen clearance and inflammatory defense. Its ability to cross the placenta makes it an important contributor to maternal-fetal immunity.

Immunoglobulin G2 (IgG2): IgG2 represents approximately 20-30% of circulating IgG and exhibits a specialized response to carbohydrate-rich antigens, particularly bacterial capsular polysaccharides. It plays an important protective role against encapsulated microorganisms, including Streptococcus pneumoniae and Haemophilus influenzae. Unlike IgG1, IgG2 generally interacts less efficiently with activating Fc receptors and has relatively limited complement-activating capacity. Nevertheless, it contributes to bacterial recognition and clearance through antibody-mediated mechanisms. Deficiencies in IgG2 may compromise the immune response to polysaccharide antigens, increasing susceptibility to recurrent respiratory tract infections, particularly during childhood.

Immunoglobulin G3 (IgG3): IgG3 is a highly specialized subclass characterized by an unusually extended hinge region, which provides considerable structural flexibility for antigen engagement. Although it accounts for approximately 5-10% of circulating IgG, it demonstrates remarkable functional potency. IgG3 is particularly effective in activating the classical complement cascade through its interaction with complement component C1q. It also exhibits strong binding to activating Fc gamma receptors, promoting opsonization, phagocytosis, and antibody-dependent cellular cytotoxicity. These properties make IgG3 an important mediator of protective immunity against certain viral and bacterial infections. However, its serum half-life is relatively short, approximately 7 days, compared with most other IgG subclasses.

Immunoglobulin G4 (IgG4): IgG4 is the least abundant subclass, accounting for approximately 3-6% of circulating IgG under normal physiological conditions. Its production is often associated with prolonged or repeated antigen exposure, including certain allergen immunotherapy responses. Unlike IgG1 and IgG3, IgG4 has minimal capacity to activate the classical complement pathway. It can undergo Fab-arm exchange, a distinctive process in which antibody molecules exchange half-molecules, producing functionally monovalent antibodies with two different antigen-binding specificities. This property limits immune complex formation and contributes to its predominantly anti-inflammatory activity. Nevertheless, excessive IgG4 production and tissue accumulation are associated with IgG4-related disease, a fibroinflammatory condition affecting multiple organs.

Structural characteristics and molecular properties of IgG

Structurally, IgG consists of four polypeptide chains: two identical heavy (γ) chains and two identical light chains (κ or λ), which are interconnected by disulfide bonds to form a characteristic Y-shaped molecular configuration (Figure 1). Each IgG molecule has a molecular weight of approximately 150 kDa and comprises two antigen-binding fragments (Fab regions) and one crystallizable fragment (Fc region), which are responsible for antigen recognition and the activation of immune effector functions, respectively. The Fab regions contain variable domains that determine antigen specificity, whereas the Fc region consists of constant domains that mediate interactions with Fc gamma receptors (FcγRs) and complement components.

Figure 1. Schematic illustration of immunoglobulin G (IgG). IgG is the perfect model for understanding the structure and function of other immunoglobulin isotypes. VH=variable heavy chain, CH=constant heavy chain, VL=variable light chain, CL=constant light chain. 

An important structural feature of IgG is its hinge region, which connects the Fab and Fc portions and provides flexibility to the antibody molecule. This flexibility allows the two antigen-binding sites to adopt different orientations, facilitating the recognition and binding of epitopes that may vary in spatial arrangement and accessibility. The monomeric organization of IgG distinguishes it from other immunoglobulin classes, including IgM, which predominantly exists as a pentamer in serum, and secretory IgA, which commonly occurs as a dimer. The relatively small molecular size and structural stability of IgG contribute to its widespread distribution in extracellular fluids and tissues.

In humans, IgG is classified into four subclasses: IgG1, IgG2, IgG3, and IgG4. Although these subclasses share a similar overall molecular structure, they differ in amino acid composition, hinge-region length, flexibility, serum abundance, and interactions with immune effector molecules. These structural variations influence their biological activities and functional specialization. IgG1 and IgG3 are particularly effective in activating the classical complement pathway and binding to Fcγ receptors, thereby promoting opsonization, phagocytosis, and ADCC. In comparison, IgG2 exhibits relatively limited complement-activating capacity and is particularly important in immune responses against bacterial polysaccharide antigens.

IgG4 has minimal ability to activate the classical complement pathway and is generally associated with anti-inflammatory responses and immune tolerance. Another important molecular characteristic of IgG is the presence of post-translational modifications, particularly N-linked glycosylation within the Fc region. The composition and structure of these attached glycans can substantially influence antibody stability, interactions with Fcγ receptors, complement activation, and overall effector activity. Variations in Fc glycosylation contribute to the regulation of inflammatory and immunological responses.

In addition to its structural and molecular properties, IgG possesses several distinctive biological characteristics. It mediates pathogen neutralization, opsonization, complement-dependent cytotoxicity, and ADCC, contributing to the elimination of infectious agents and abnormal cells. Moreover, IgG is the only immunoglobulin class capable of efficiently crossing the placenta through interaction with the neonatal Fc receptor (FcRn), thereby providing passive immunity to the developing fetus and newborn. Its molecular architecture, subclass diversity, and functional adaptability establish IgG as a critical component of humoral immunity, immune regulation, and long-term protection against infectious diseases.

Functions of immunoglobulin G

Immunoglobulin G performs several essential functions in the immune system by identifying foreign substances, neutralizing harmful agents and coordinating cellular and molecular defense mechanisms. As the predominant antibody in human serum, it provides targeted protection against invading microorganisms, toxins and other antigens. Its protective activities extend beyond antigen recognition, involving interactions with immune cells, complement proteins and various biological pathways. The major functions of IgG include:

Neutralization of toxins and viruses: IgG protects the body through neutralization, a process in which antibodies bind specifically to toxins, viruses and other harmful substances. By attaching to critical sites on these agents, IgG prevents them from interacting with host-cell receptors or entering susceptible cells. This action restricts the biological activity of toxins and limits viral attachment, penetration and subsequent replication. Neutralization is particularly important in controlling infections and preventing the spread of pathogens throughout the body.

Opsonization and enhancement of phagocytosis: IgG facilitates the elimination of microorganisms through a mechanism known as opsonization. During this process, IgG molecules attach to the surfaces of bacteria and other foreign particles, effectively marking them for destruction. The exposed Fc regions of these antibodies are recognized by Fc gamma receptors (Fcγ receptors) on phagocytic cells, particularly macrophages and neutrophils. This interaction promotes pathogen engulfment, intracellular digestion and removal. IgG strengthens the efficiency of innate immune cells in eliminating infectious agents.

Activation of the classical complement pathway: Certain IgG subclasses participate in complement activation, an important mechanism of immune defense. When IgG antibodies bind to antigens, their Fc regions can recruit C1q, initiating the classical complement cascade. This process stimulates a series of enzymatic reactions that facilitate inflammation, pathogen opsonization and, in susceptible microorganisms, membrane attack complex formation. IgG1 and IgG3 are particularly effective complement activators, whereas IgG2 has more limited activity and IgG4 generally does not activate this pathway effectively.

Antibody-dependent cellular cytotoxicity (ADCC): IgG contributes to the destruction of infected and abnormal cells through antibody-dependent cellular cytotoxicity. In this mechanism, antibodies recognize and bind to antigens displayed on the surfaces of target cells. Natural killer (NK) cells subsequently recognize the Fc portions of these antibodies through their FcγRIII (CD16) receptors. This interaction stimulates NK cells to release cytotoxic substances, including perforin and granzymes, which induce target-cell death. ADCC is an important mechanism for controlling certain viral infections and eliminating abnormal cells.

Agglutination of foreign particles: IgG contributes to agglutination by binding simultaneously to antigens on separate microorganisms or particles, encouraging their aggregation. Although IgG is less efficient at agglutination than pentameric IgM, its two antigen-binding sites enable the formation of antigen–antibody complexes. These aggregates can restrict pathogen movement and facilitate their recognition and clearance by phagocytic cells. This mechanism therefore supports the removal of foreign materials from circulation.

Regulation of immune responses: Beyond direct pathogen elimination, IgG participates in the modulation of immune activity. Antigen-antibody complexes interact with Fcγ receptors on immune cells, influencing cellular activation, inflammatory signaling and antibody production. Depending on the receptor involved and the surrounding conditions, these interactions can either enhance or suppress immune responses. Inhibitory FcγRIIB receptors, for example, help limit excessive B-cell activation and antibody production. Through these regulatory mechanisms, IgG contributes to immune balance and helps prevent unnecessary tissue damage.

Formation and clearance of immune complexes: IgG binds to soluble antigens to form immune complexes, which are subsequently transported and eliminated through specialized clearance mechanisms. Complement proteins, particularly C3b, can associate with these complexes and facilitate their recognition by complement receptors on phagocytic cells. Erythrocytes also contribute to their transportation to the liver and spleen, where macrophages remove them from circulation. Efficient clearance prevents excessive immune-complex accumulation and reduces the risk of inflammatory tissue injury.

Role of IgG in secondary immune response and immunological memory

Immunoglobulin G is a principal effector antibody of the secondary immune response, contributing significantly to immunological memory and sustained humoral protection. Its production is closely associated with the activation and differentiation of antigen-specific B lymphocytes following an initial encounter with a foreign antigen. During the primary immune response, naïve B cells recognize specific antigenic determinants and undergo clonal expansion. With appropriate assistance from T follicular helper (Tfh) cells, activated B cells undergo class-switch recombination, enabling them to produce IgG instead of IgM while retaining the same antigen specificity.

Some of these activated cells differentiate into long-lived plasma cells, whereas others develop into memory B cells that persist after the initial infection has subsided. Upon subsequent exposure to the same antigen, memory B cells undergo rapid clonal reactivation and differentiate into antibody-secreting plasma cells. This process generates a secondary antibody response characterized by accelerated kinetics, elevated IgG concentrations, and enhanced antigen-binding affinity. The increased binding efficiency results from somatic hypermutation and affinity-based selection, which occur during germinal-centre reactions.

IgG becomes the predominant antibody isotype in many secondary humoral responses, enabling the immune system to recognize and eliminate previously encountered pathogens with greater efficiency. The protective capacity of IgG is mediated through several interconnected effector mechanisms. One important mechanism is antigen neutralization, whereby IgG binds to specific epitopes on viral particles, bacterial toxins, and other microbial products, obstructing their attachment to host-cell receptors or interfering with their biological activities.

Another essential mechanism is opsonophagocytosis, in which IgG molecules coat microbial surfaces and facilitate their recognition by FcγRs expressed on macrophages, neutrophils, and other phagocytic cells. Engagement of these receptors stimulates pathogen engulfment and subsequent intracellular degradation, thereby accelerating microbial clearance. IgG contributes to innate immune effector activity through activation of the classical complement cascade. When appropriately clustered on antigenic surfaces, the Fc regions of IgG molecules interact with complement component C1q, initiating a sequence of proteolytic reactions.

This activation promotes C3b deposition, enhances opsonization, generates inflammatory mediators, and, under suitable conditions, facilitates microbial membrane disruption through the membrane attack complex (C5b-C9). IgG also participates in ADCC, particularly through interactions with FcγRIII (CD16) on natural killer cells, resulting in the destruction of antibody-coated infected or abnormal cells.

The prolonged persistence of IgG in the bloodstream further strengthens immunological memory by maintaining circulating antigen-specific antibodies. In humans, IgG has an approximate serum half-life of 21 days, although this varies among its four subclasses. Its extended longevity is largely attributed to the FcRn, which binds internalized IgG within acidic endosomal compartments and prevents its delivery to lysosomes for degradation. The receptor subsequently facilitates IgG recycling and release back into the extracellular circulation at physiological pH.

Through this salvage pathway, IgG maintains relatively stable serum concentrations and provides sustained antibody-mediated protection. The rapid activation of memory B cells, affinity-enhanced antigen recognition, diverse Fc-mediated effector functions, and FcRn-dependent antibody recycling establish IgG as a fundamental component of long-term adaptive immunity. These mechanisms contribute to durable protection following natural infection and vaccination, while improving the immune system’s capacity to control repeated encounters with previously recognized antigens.

Placental transfer of IgG and its protective immunity in neonates

One of the most distinctive biological properties of IgG is its ability to cross the placental barrier. Unlike other immunoglobulin classes, IgG is actively transported from the maternal circulation to the fetal bloodstream through FcRn-mediated transcytosis in placental syncytiotrophoblasts. This selective transfer begins in the second trimester of pregnancy and increases significantly during the third trimester, resulting in higher concentrations of maternal IgG in the newborn at birth.

Neonates acquire passive humoral immunity that protects them against pathogens encountered by the mother. Maternal IgG provides temporary immune defense during the first six months of life, a period when the infant’s immune system is still immature and has limited capacity to mount robust antibody responses. This passive immunity is particularly important for protection against respiratory infections, systemic bacterial infections, and certain viral diseases. The effectiveness of placental IgG transfer depends on subclass specificity and maternal antibody levels.

IgG1 is transferred most efficiently, followed by IgG4, IgG3, and IgG2. Vaccination during pregnancy leverages this physiological mechanism to enhance neonatal immunity against preventable infectious diseases such as influenza, pertussis, and tetanus. However, maternal IgG can also have clinical implications beyond protection. In some cases, pathogenic autoantibodies or alloantibodies cross the placenta and contribute to neonatal autoimmune or hemolytic conditions. This demonstrates that while placental IgG transfer is protective, it can also mediate disease under certain immunological circumstances.

Immunoglobulin G is the most predominant antibody class in blood serum and extracellular fluids, accounting for approximately 80% of the total immunoglobulin pool. Its monomeric structure, subclass diversity, and functional versatility enable it to play a central role in adaptive immunity. Through participation in secondary immune responses, IgG ensures rapid and high-affinity antibody production upon antigen re-exposure. Its ability to neutralize pathogens, mediate opsonization, activate complement, and engage Fc receptors underscores its importance in immune defense.

IgG is the only immunoglobulin class capable of crossing the placental barrier, thereby conferring passive immunity to the newborn during the early months of life. This transplacental transfer highlights its critical role in intergenerational immune protection. IgG represents a fundamental component of humoral immunity, bridging innate immune mechanisms with long-term adaptive protection and contributing to both clinical immunity and vaccine-mediated disease prevention.

Role of IgG in passive immunity and maternal-fetal protection

Immunoglobulin G possesses a distinctive immunological property that enables maternal antibodies to cross the placental barrier and establish passive immunity in the developing fetus. This process, known as transplacental antibody transfer, is mediated by the FcRn, which facilitates the selective uptake, intracellular transport and release of maternal IgG across placental cells. Unlike other immunoglobulin classes, IgG is the only antibody class transferred across the human placenta in substantial quantities, making it a principal mediator of prenatal humoral protection.

The efficiency of this transfer increases progressively as pregnancy advances, particularly during the second and third trimesters, with the greatest accumulation occurring towards the end of gestation. The concentration of IgG in fetal circulation may approach or even exceed maternal serum levels at birth. Through this physiological mechanism, the fetus acquires a diverse collection of maternal antibodies generated following previous infections, immunological exposures or vaccination. These transferred antibodies provide antigen-specific protection against various infectious agents without requiring direct exposure of the fetus to the corresponding pathogens.

Following delivery, maternally acquired IgG remains biologically active within the neonatal circulation, where it participates in pathogen neutralization, opsonization and other antibody-mediated defense mechanisms. This protection is particularly consequential during the first months of life, when neonatal immune responses are still developing and endogenous antibody production has not yet attained full functional maturity. Maternal IgG therefore serves as an immunological bridge between prenatal development and the establishment of independent adaptive immune competence.

The protective influence of maternal IgG is temporary rather than permanent. As the infant grows, maternally derived antibodies undergo progressive metabolic degradation and clearance, resulting in a gradual reduction in circulating concentrations over the first several months after birth. The rate of decline varies according to antibody specificity, initial concentration and individual metabolic factors. This transition creates an important period during which passive antibody protection diminishes while the infant’s own immune system progressively develops antigen recognition, antibody synthesis and immunological memory.

The availability of maternal IgG during this vulnerable developmental phase contributes substantially to early resistance against respiratory infections, bacterial pathogens and selected viral diseases. Beyond its physiological contribution to maternal-fetal protection, IgG also has considerable therapeutic relevance in clinical immunology. Passive immunization involves the administration of preformed antibodies to provide immediate but temporary protection against specific infectious agents or immune deficiencies.

Intravenous immunoglobulin (IVIG), prepared from pooled plasma donations obtained from numerous healthy individuals, represents an important clinical application of IgG. Its administration supplies a broad spectrum of antibodies and can also exert immunomodulatory effects in selected autoimmune, inflammatory and immunodeficiency conditions. Thus, IgG functions not only as a naturally transferred maternal antibody but also as a valuable therapeutic resource for augmenting humoral defence and regulating pathological immune activity.

Complement activation and antibody-dependent cellular cytotoxicity

One of the key immunological functions of IgG is its ability to activate the complement system, although it is considered a moderate complement-fixing antibody relative to other immunoglobulin classes. Complement activation primarily occurs through the classical pathway, which is initiated when the Fc region of antigen-bound IgG interacts with the C1 complex. This interaction triggers a cascade of proteolytic events leading to opsonization, inflammation, and the formation of the membrane attack complex.

The efficiency of complement activation depends on antibody density, subclass type, and spatial arrangement of IgG molecules on antigen surfaces. IgG3 and IgG1 subclasses demonstrate stronger complement fixation because of their Fc structural configuration, whereas IgG4 exhibits minimal complement activation capacity. Through complement deposition, pathogens are marked for enhanced phagocytosis by macrophages and neutrophils, contributing to pathogen clearance.

In addition to complement activation, IgG mediates ADCC, an essential effector mechanism in immune defense against infected or transformed cells. ADCC occurs when IgG antibodies bind to specific antigens expressed on target cells. Effector cells such as natural killer (NK) cells, macrophages, and neutrophils express Fc gamma receptors (FcγRs) that recognize the Fc portion of bound IgG. Upon FcγR engagement, effector cells release cytotoxic molecules including perforin and granzymes or produce inflammatory mediators that induce apoptosis of the target cell.

This mechanism is particularly important in viral infections, tumor surveillance, and clearance of antibody-coated cells. The effectiveness of ADCC depends on the affinity between IgG Fc domains and Fc receptors, as well as the level of antigen expression on target cells. Therapeutic monoclonal antibodies used in oncology frequently exploit ADCC as a major mechanism of action. Immunoglobulin G (IgG) is typically produced during the later stages of an immune response and remains detectable in the circulation for an extended period compared with other immunoglobulin isotypes. Its delayed appearance reflects class-switch recombination and affinity maturation processes that occur following initial antigen exposure.

Once generated, IgG contributes to long-term humoral immunity and serves as a key marker of past or ongoing infection. IgG binds specifically to antigens expressed on pathogenic microorganisms, including bacteria and viruses. This antigen-antibody interaction promotes immune clearance through several effector mechanisms. One of the primary functions of IgG is opsonization, whereby the antibody coats the surface of the pathogen and enhances its recognition by phagocytic cells such as macrophages and neutrophils. The Fc region of IgG interacts with Fc gamma receptors on phagocytes, facilitating efficient engulfment and intracellular destruction of the targeted microorganism.

As a result, opsonized microbes are phagocytosed more readily than non-opsonized antigens, significantly improving host defense. Beyond opsonization, IgG also participates in complement activation via the classical pathway, leading to the deposition of complement components on microbial surfaces. This process further enhances phagocytosis and can directly contribute to microbial lysis. In addition, IgG mediates ADCC, where immune effector cells recognize IgG-coated targets and induce targeted cell death. These combined mechanisms underscore the central role of IgG in adaptive immunity and pathogen clearance.

IgG is widely utilized in immunological research and diagnostic applications because of its relatively high concentration in serum and plasma, as well as its strong affinity and specificity for antigens. Its stability and well-characterized structure make it suitable for assays such as enzyme-linked immunosorbent assays (ELISA), immunoblotting, immunofluorescence, and neutralization studies. Purified IgG antibodies are commonly employed as research reagents and therapeutic agents due to their predictable binding properties and functional versatility.

Role of IgG in immunological research and diagnostic applications 

IgG plays a central role in immunology as both a functional effector molecule in adaptive immunity and a critical tool in diagnostic and translational research. Its biochemical stability, high specificity, and abundance in serum make it indispensable for experimental immunology, disease diagnostics, vaccine evaluation, and therapeutic development. IgG continues to remains a cornerstone of immunological experimentation, diagnostic assay development, and therapeutic innovation due to its specificity, functional versatility, and clinical relevance.

In immunological research, IgG is widely used as a detection and analytical reagent. Purified IgG antibodies are generated against specific antigens and employed in techniques such as enzyme-linked immunosorbent assay (ELISA), Western blotting, immunoprecipitation, immunofluorescence microscopy, and flow cytometry. In these applications, IgG serves as a primary antibody that recognizes target proteins, pathogens, or cellular markers with high specificity. Secondary antibodies often anti-IgG conjugated to enzymes, fluorophores, or nanoparticles are used to amplify detection signals. This dual-antibody system enhances assay sensitivity and allows quantitative or qualitative measurement of antigens.

IgG is also fundamental in studying immune responses to infection and vaccination. The measurement of antigen-specific IgG titers provides insight into humoral immunity and immune memory. In vaccine research, quantification of vaccine-induced IgG responses is used as a correlate of protection, helping researchers assess immunogenicity and durability of immune responses. Neutralizing IgG antibodies, which block pathogen entry into host cells, are particularly important in evaluating vaccine efficacy against viral infections. Longitudinal monitoring of IgG levels enables assessment of antibody kinetics, seroconversion rates, and long-term immune persistence.

In diagnostic applications, IgG-based assays are extensively used for serological testing. Detection of pathogen-specific IgG in patient serum indicates prior exposure or infection. For many infectious diseases, including viral, bacterial, and parasitic infections, IgG testing is used to determine immune status, past infection, or vaccine-induced immunity. Because IgG persists longer in circulation compared with IgM or IgA, it serves as a reliable biomarker for historical exposure. Diagnostic platforms such as rapid diagnostic tests, lateral flow immunoassays, and chemiluminescent immunoassays commonly rely on IgG detection for clinical screening and surveillance.

Beyond infectious disease diagnostics, IgG is important in autoimmune disease research and clinical testing. Autoantibodies (which are self-reactive IgG molecules) are key biomarkers in conditions such as systemic lupus erythematosus, rheumatoid arthritis, and autoimmune thyroid disease. Detection of disease-associated IgG autoantibodies assists in diagnosis, disease classification, and monitoring of disease progression. In addition, characterization of IgG subclasses helps researchers understand pathogenic mechanisms, as different subclasses exhibit distinct effector functions and inflammatory potentials.

Therapeutically, IgG forms the basis of monoclonal antibody (mAb) development and antibody-based biologics. Engineered IgG antibodies are used to target cancer cells, neutralize toxins, inhibit inflammatory pathways, or block viral entry. Advances in recombinant DNA technology and hybridoma techniques have enabled the production of highly specific monoclonal IgG antibodies for clinical use. IVIG, which consists primarily of pooled IgG from donors, is also applied in immunodeficiency treatment and autoimmune disease management due to its immunomodulatory properties.

IgG is utilized in biomarker discovery and proteomics research. Antibody-based affinity purification enables enrichment of specific proteins or immune complexes from biological samples for downstream mass spectrometry analysis. This approach facilitates identification of disease-associated proteins and signaling molecules.

Disorders and abnormalities associated with immunoglobulin G

Immunoglobulin G is indispensable for maintaining immune protection through antigen recognition, pathogen neutralization, and regulation of inflammatory responses. However, disturbances in its concentration, subclass distribution, or antibody activity can compromise immune homeostasis and contribute to various pathological conditions. These abnormalities may arise from impaired antibody synthesis, excessive immunoglobulin production, persistent antigenic stimulation, or inappropriate immune recognition of self-antigens. The major disorders associated with IgG include:

Hypogammaglobulinemia: Hypogammaglobulinemia refers to a reduction in circulating immunoglobulin levels, particularly IgG, resulting from inadequate antibody production or increased immunoglobulin loss. This condition weakens humoral immune defence and predisposes affected individuals to recurrent bacterial infections, especially those involving the respiratory and gastrointestinal tracts. It may occur in primary immunodeficiency disorders, certain haematological malignancies, or as a consequence of immunosuppressive medications. Persistent cases can impair the body’s ability to establish effective protection against previously encountered pathogens.

Hypergammaglobulinemia: Hypergammaglobulinemia describes an abnormal elevation in serum immunoglobulin concentrations, including IgG. It commonly develops following prolonged immune stimulation associated with chronic infections, inflammatory conditions, and autoimmune disorders. The increase may be polyclonal, involving multiple antibody-producing cell populations, or monoclonal, arising from a single expanding plasma-cell clone. Although elevated IgG may reflect sustained immune activity, excessive or dysregulated antibody production can accompany underlying pathological processes.

Multiple myeloma: Multiple myeloma is a malignant plasma-cell disorder characterized by uncontrolled proliferation of abnormal antibody-producing cells within the bone marrow. In some patients, these cells produce excessive quantities of a single, structurally identical IgG molecule, known as monoclonal IgG or an M-protein. This abnormal accumulation may interfere with normal blood-cell formation, weaken immune competence, and contribute to bone destruction, anaemia, kidney impairment, and increased susceptibility to infections. Serum protein electrophoresis and immunofixation are important investigations for detecting monoclonal immunoglobulins.

IgG subclass deficiency: IgG subclass deficiency occurs when one or more of the four IgG subclasses (IgG1, IgG2, IgG3, and IgG4) are present at abnormally low concentrations despite a potentially normal total IgG level. Each subclass performs distinct immunological functions; therefore, a deficiency may selectively compromise responses to particular antigens. For example, reduced IgG2 can impair antibody responses against polysaccharide-coated bacteria. Affected individuals may experience recurrent sinusitis, otitis media, bronchitis, and other respiratory infections. Diagnosis requires subclass measurement and assessment of specific antibody responses.

IgG-mediated autoimmune diseases: In certain autoimmune conditions, IgG antibodies mistakenly recognize and bind to the body’s own cellular structures, forming autoantibodies. These antibodies may activate complement, promote inflammation, or interfere with normal receptor function. Examples include systemic lupus erythematosus, autoimmune haemolytic anaemia, and Graves’ disease. Their pathological effects depend on the targeted antigen and the mechanisms through which antibody binding disrupts normal tissue physiology.

IgG4-related disease: IgG4-related disease is a chronic, immune-mediated fibroinflammatory disorder characterized by tumour-like tissue enlargement, dense lymphoplasmacytic infiltration, and progressive fibrosis. It can affect several organs, including the pancreas, salivary glands, kidneys, and bile ducts. Although elevated serum IgG4 concentrations may occur, they are not sufficient to establish the diagnosis independently. Tissue examination, clinical findings, and appropriate imaging are important for confirmation. Untreated disease may result in irreversible organ damage.

References

Abbas A.K, Lichtman A.H and Pillai S (2010). Cellular and Molecular Immunology. Sixth edition. Saunders Elsevier Inc, USA.

Actor J (2014). Introductory Immunology. First edition. Academic Press, USA.

Bach F and Sachs D (1987). Transplantation immunology. N. Engl. J. Med. 317(8):402-409.

Barrett   J.T (1998).  Microbiology and Immunology Concepts.  Philadelphia,   PA:  Lippincott-Raven Publishers. USA.

Jaypal V (2007). Fundamentals of Medical Immunology. First edition. Jaypee Brothers Medical Publishers (P) Ltd, New Delhi, India.

Levinson W (2010). Review of Medical Microbiology and Immunology. Twelfth edition. The McGraw-Hill Companies, USA.

Roitt I, Brostoff J and Male D (2001). Immunology. Sixth edition. Harcourt Publishers Limited, Spain.

Zon LI (1995). Developmental biology of hematopoiesis. Blood, 86(8): 2876–91.


Discover more from Microbiology Class

Subscribe to get the latest posts sent to your email.

Leave a Reply

Discover more from Microbiology Class

Subscribe now to keep reading and get access to the full archive.

Continue reading